Finance News – Cvs
What is your interest today?
Tariffs
Ceo
Investors
Stock
Earnings
Shares
Stocks
Markets
China
Trade
Investment
Revenue
Economy
Nasdaq
Wall street
Warren buffett
Stock market
Eqs
Berkshire hathaway
Inflation
Trade war
Nvidia
Prices
Cet
U.s.
Company
Amazon
Apple
Guidance
Class action
Sales
Federal reserve
Securities
Bitcoin
S&p 500
Trading
Crypto
Ipo
Forecast
Corporate
Microsoft
Recession
Tesla
Interest rates
Companies
Gold
Imports
Shareholders
Meta
Pvr
Dell
Robinhood
Ppta
Market losses
China ai market
Bankruptcy
Fundamentals
Chip company
Revenue growth
Retail investors
= 1024) { setSearchBy('title'); suggestionOpen = true; fetch() }"
@input.debounce.300ms="window.innerWidth >= 1024 && fetch()"
@keydown.enter.prevent="window.innerWidth >= 1024 && submitSearch()"
placeholder="Search finance news…"
class="flex-grow bg-transparent border-0 focus:ring-0
px-4 py-2 placeholder-gray-500 dark:placeholder-gray-400
text-gray-900 dark:text-gray-100 mr-2"
/>
CNBC Business • May 01, 2025
CVS tops estimates, hikes guidance as insurance business shows some improvement
CVS has raised its full-year earnings forecast to between $6 and $6.20 per share due to positive developments in its insurance sector, surpassing previous expectations.
Read Full Article →
CNBC Business • May 01, 2025
CVS to boost access to Novo Nordisk's weight loss treatment Wegovy for patients on its drug plans
Starting July 1, Caremark will prioritize Wegovy on its formulary, improving accessibility for patients on its drug plans and potentially increasing the treatment's market presence...
Read Full Article →